Harvard Bioscience, Inc. (HBIO)
Largest Insider Buys in Sector
HBIO Stock Price History Chart
HBIO Stock Performance
About Harvard Bioscience, Inc.
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate …
Insider Activity of Harvard Bioscience, Inc.
Over the last 12 months, insiders at Harvard Bioscience, Inc. have bought $90,500 and sold $0 worth of Harvard Bioscience, Inc. stock.
On average, over the past 5 years, insiders at Harvard Bioscience, Inc. have bought $222,280 and sold $1.16M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Green James W (Chief Executive Officer) — $181,000.
The last purchase of 10,000 shares for transaction amount of $29,100 was made by Green James W (Chief Executive Officer) on 2024‑06‑13.
List of Insider Buy and Sell Transactions, Harvard Bioscience, Inc.
| 2024-06-13 | Chief Executive Officer | 10,000 0.0242% | $2.91 | $29,100 | -7.56% | |||
| 2024-06-06 | Chief Executive Officer | 20,000 0.0474% | $3.07 | $61,400 | -8.89% | |||
| 2023-08-17 | Chief Executive Officer | 25,000 0.06% | $4.38 | $109,500 | -1.39% | |||
| 2023-03-15 | Chief Executive Officer | 20,000 0.0468% | $2.60 | $52,000 | +71.21% | |||
| 2023-03-15 | director | 16,192 0.0382% | $2.62 | $42,423 | +71.21% | |||
| 2023-03-14 | Chief Executive Officer | 20,000 0.0475% | $2.67 | $53,400 | +69.29% | |||
| 2023-03-14 | director | 13,808 0.0328% | $2.67 | $36,867 | +69.29% | |||
| 2022-12-01 | Chief Executive Officer | 15,000 0.0341% | $2.61 | $39,150 | +54.15% | |||
| 2022-11-30 | Chief Executive Officer | 15,000 0.0341% | $2.41 | $36,150 | +66.60% | |||
| 2022-08-26 | 9,291 0.0231% | $3.41 | $31,682 | -5.78% | ||||
| 2022-08-24 | 8,244 0.0207% | $3.34 | $27,535 | -2.82% | ||||
| 2022-08-22 | 4,918 0.0118% | $3.16 | $15,541 | -2.21% | ||||
| 2022-08-18 | 1,151 0.0028% | $3.19 | $3,672 | -2.52% | ||||
| 2022-08-17 | Chief Executive Officer | 40,000 0.0961% | $3.19 | $127,600 | -2.82% | |||
| 2022-06-15 | Chief Executive Officer | 30,000 0.0734% | $3.71 | $111,300 | -15.53% | |||
| 2022-05-06 | Chief Executive Officer | 10,000 0.0219% | $3.40 | $34,000 | -17.55% | |||
| 2021-08-23 | Sale | Chief Executive Officer | 48,175 0.1175% | $8.02 | $386,364 | -26.02% | ||
| 2021-05-21 | Sale | Chief Executive Officer | 24,312 0.0605% | $7.14 | $173,588 | -2.52% | ||
| 2021-05-20 | Sale | Chief Executive Officer | 14,876 0.0372% | $7.03 | $104,578 | -0.43% | ||
| 2021-05-18 | Sale | Chief Executive Officer | 39,188 0.0988% | $7.41 | $290,383 | -4.37% |
Insider Historical Profitability
| Green James W | Chief Executive Officer | 3111091 7.1328% | $2.09 | 16 | 5 | +24.69% |
| Skystone Advisors LLC | 10 percent owner | 3744819 8.5858% | $2.09 | 64 | 5 | +9.98% |
| GRAZIANO CHANE | 10 percent owner | 3105150 7.1192% | $2.09 | 5 | 0 | +21.41% |
| HSO LIMITED PARTNERSHIP | 10 percent owner | 2757257 6.3216% | $2.09 | 40 | 2 | +8.24% |
| GREEN DAVID | director | 925571 2.1221% | $2.09 | 15 | 73 | +46.82% |
Institutional Investor Ownership
| B Riley Asset Management Llc | $12.02M | 6.53 | 2.83M | -3.55% | -$442,388.89 | 4.94 | |
| BlackRock | $12.01M | 6.53 | 2.83M | -2.75% | -$339,836.02 | <0.0001 | |
| Punch & Associates Investment Management, Inc. | $11.75M | 6.38 | 2.77M | -4.99% | -$617,746.78 | 0.68 | |
| Harvey Partners | $10.84M | 5.89 | 2.56M | 0% | +$0 | 1.21 | |
| Amh Equity Ltd | $9.85M | 5.35 | 2.32M | +7.46% | +$683,941.68 | 12.77 |